Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Shortages Are A Matter Of Time As Bill Sponsors Work To Show Warnings Will Help

Executive Summary

Supporters of pending legislation on drug shortages face a challenge of time – demonstrating that the extra time the advance-warning system would provide is worth the legislative time and effort to create it.

You may also be interested in...

To Prevent Drug Shortages, Don't Look To Inspections, FDA Says

Agency maintains its inspection policy does not cause or prevent shortages.

Inspection Improvements Could Help Fight Drug Shortages, Hospital Group Says

Senators also have requested a GAO study of the nature of drug shortages and FDA's ability to respond to them.

Not Another FDAAA – Observers Expect Fewer FDA Reforms In PDUFA V

Congress is not expected to pile as many new responsibilities on FDA in the upcoming Prescription Drug User Fee Act reauthorization as in 2007’s FDA Amendments Act.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts